is semaglutide discontinued An Ongoing Crisis: Shortage Raises Dual Concerns for Obesity and Diabetes Treatment Research shows semaglutide — commonly

On average, PBMs help patients and employers save over $1,100 per person each year by negotiating drug prices On April 1, 2026, the FDA approved Eli Lillys Foundayo, the second oral GLP1 for weight loss offering fewer administration restrictions and achieving one of the fastest newdrug approvals in decades. On March 26, 2026, the FDA approved Awiqli (insulin icodec abae) from Novo Nordisk the first onceweekly basal insulin for adults with type 2 diabetes

Reader voices Editorially-curated synthesis of public Trustpilot reviews and community-forum discussion

Maintaining 30-50 grams of healthy fats daily prevents bile sludge formation during rapid weight loss

[1] Figure 2

For patients with high cardiovascular risk, the protective effects of GLP-1 receptor agonists typically justify continued therapy in the absence of concerning symptoms

"Weight Loss Products." tricare.mil Military Times